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Abstract
Background: Milk formulas have higher protein contents than human milk. This high protein level could modify the
development of intestinal microbiota, epithelial barrier and immune functions and have long-term consequences.
Methodology/Principal findings: We investigated the effect of a high protein formula on ileal microbiota and physiology
during the neonatal period and later in life. Piglets were fed from 2 to 28 days of age either a normoprotein (NP, equivalent
to sow milk) or a high protein formula (HP, +40% protein). Then, they received the same solid diet until 160 days. During the
formula feeding period ileal microbiota implantation was accelerated in HP piglets with greater concentrations of ileal
bacteria at d7 in HP than NP piglets. Epithelial barrier function was altered with a higher permeability to small and large
probes in Ussing chambers in HP compared to NP piglets without difference in bacterial translocation. Infiltration of T cells
was increased in HP piglets at d28. IL-1b and NF-kB sub-units mRNA levels were reduced in HP piglets at d7 and d28
respectively; plasma haptoglobin also tended to be reduced at d7. Later in life, pro-inflammatory cytokines secretion in
response to high doses of LPS in explants culture was reduced in HP compared to NP piglets. Levels of mRNA coding the
NF-kB pathway sub-units were increased by the challenge with LPS in NP piglets, but not HP ones.
Conclusions/Significance: A high protein level in formula affects the postnatal development of ileal microbiota, epithelial
barrier and immune function in piglets and alters ileal response to inflammatory mediators later in life.
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Introduction
Although human breast milk is the optimal nutrition during
infancy, many infants are still formula-fed for practical or medical
reasons. Milk formula composition has been improved during the
last decades to tend to resemble human milk. Cow’s milk protein is
the major source of protein in formulas but due to difference in
protein and amino acid digestibility, bioavailability and efficiency
of utilization between human milk and formula, the amount of
protein per energy content has generally been higher in formula
than in human milk to meet the protein and amino acid
requirements of infants (up to 2.5 g/100 kcal for the formula,
i.e. up to 40% more proteins than in human breast milk) [1,2].
Although the current tendency is to reduce protein level in formula
for full term healthy babies, numerous babies have been fed such
formula for years during the last decades. The use of high protein
formula is still encouraged in at risk populations such as low birth
weight babies who had suffered intra-uterine growth restriction to
ensure a rapid post-natal catch up growth [3,4]. Yet, such
nutritional practice seems to have long-term metabolic conse-
quences [5,6].
At the intestinal level, the interplay between gut bacterial
colonization, epithelial barrier and gut associated-lymphoid tissue
(GALT) plays a crucial role in the development of intestinal
function and maturation of the immune system during the first
months of life in neonates. The type of bacteria colonizing the
intestine of newborns and the timing determine the immunomod-
ulation of the naı ¨ve GALT [7]. Studies in infants with prebiotics
and probiotics suggest that manipulations of the microbiota early
in life affect the immune system [8]. The physical barrier formed
by the intestinal epithelium is also crucial since bacterial
translocation has been shown to be required for the neonate to
achieve GALT development [9]. This interplay can be modulated
by a fourth factor, namely food. Indeed, food components may be
the source of antigens to which the immune system must become
tolerant and antigens might themselves modulate immune
maturation. Food also provides factors or nutrients that influence
the intestinal microbiota and epithelial barrier function, which in
turn will affect antigen exposure, immune maturation and immune
function [10].
Although high protein formulas have been or are still commonly
used in neonates, the role of high levels of protein as modulators of
PLoS ONE | www.plosone.org 1 May 2011 | Volume 6 | Issue 5 | e19594intestinal microbiota and epithelial and immune cells has been
poorly investigated. In adults, a high protein diet has been shown
to increase lactic acid bacteria in ileal digesta of human adults [11]
and supplementation of the diet with a mixture of amino acids
increases the total number of faecal bacteria in a model of colitis in
adult rats [12]. Specific amino acids such as glutamine have been
shown to enhance barrier function in cell culture or animal models
[13]. Finally, presence of proteins and therefore antigenic
structures in the diet has been shown to be essential in the
maturation of the GALT in mice [14]. We hypothesized that, as
described in adults, a high level of protein in infant formula will
modulate intestinal microbiota and non-immune and immune
intestinal barrier development. Moreover, regarding the key role
of the neonatal period in GALT maturation, we also hypothesized
that early modifications of intestinal ecology and physiology would
impact intestinal sensitivity to inflammation later in life. We
therefore compared the postnatal development of ileal microbiota,
epithelial permeability and immune function of piglets fed two
types of formula differing in their protein content: close to sow
milk or with 40% more protein per unit of energy. In a follow-up
experiment we evaluated the long-term effects of this high protein
formula on intestinal sensitivity to inflammation.
Results
Piglet growth
The mean protein intake over the whole experimental period (d
2–d 28) in the first experiment was 35% higher for HP compared
to NP piglets (17.560.2 vs 12.660.2 g.d
21.kg of metabolic
weight
21, P,0.001) but with similar energy intakes (116569v s
1183614 kJ.d
21.kg of metabolic weight
21, P.0.05) as expected.
The HP diet enhanced piglet growth from the 16
th day of life, with
a 19% higher daily weight gain relative to the initial birth weight
in HP compared to NP piglets (188610 vs 158610 g.d
21.kg of
birth weight
21, P=0.02) over the whole experimental period.
Similar increase in daily weight gain during the formula-feeding
period was observed with HP piglets in the follow-up experiment
(data not shown). After weaning, no difference in feed intake and
daily weight gain was observed between the two groups of animals
(feed intake: NP 4661 vs HP: 4561 g.kg
21.d
21,P .0.05; daily
weight gain: NP 755611 vs HP 751611 g.d
21,P .0.05). The
final body weight at slaughter did not differ between groups (NP
11668 vs HP 11467 kg, P.0.05).
Ileal microbiota during the neonatal period
To test our hypothesis of a stimulatory effect of the HP formula
on microbiota growth, we measured the concentration of aerobic
and anaerobic bacteria in ileal contents. A higher concentration of
total aerobes and anaerobes in the ileal contents of HP compared
to NP piglets was observed at d 7 (Table 1). Mucosal-adherent
bacteria were then analysed to evaluate if this higher concentra-
tion of bacteria induced an increase in the number of bacteria
actually in contact with the mucosa. However, no change in the
total number of aerobes or anaerobes bacteria adherent to the ileal
mucosa was observed (Table 1). Nonetheless, while the concen-
tration of Lactobacillus was increased in ileal contents, the number
of Lactobacillus adherent to the mucosa was lower in HP than NP
piglets at d 7 (Table 1).
Epithelial barrier function during the neonatal period
The effect of the HP formula on the physical barrier formed by
epithelial cells was assessed by the measurement of in vivo bacterial
translocation. Bacterial translocation to the lower mesenteric
lymph nodes or to the spleen did not vary significantly between the
two formulas, irrespective of age (data not shown). Since bacterial
translocation reflects both epithelial barrier function and GALT
capacity to neutralize bacteria, we also measured ileal permeability
to small probes (FD-4) or macromolecules (HRP) ex vivo in Ussing
chambers to evaluate specifically epithelial barrier function. The
HP formula induced drastic changes in ileal permeability since
FD-4 fluxes across mucosa was 2.9-fold higher in HP compared to
NP piglets at d 7 (P=0.03, Figure 1 A) and HRP fluxes 24-fold
and 3-fold higher in HP than NP piglets at d 7 and 28 respectively
(P=0.03 and 0.05 respectively, Figure 1 B).
Intestinal immune system during the neonatal period
The changes in ileal microbiota and epithelial barrier function
induced by the HP formulaprompted us to evaluate the development
of the GALT. Since the neonatal period is an intensive period of
immune cell recruitment in the lamina propria, we first assessed the
effect of the HPformulaon myeloid cells (CD172 positive cells) and T
cells (CD3 positive cells) densities in the ileal lamina propria. No
change was observed at d 7 (data not shown). At d 28 myeloid cells
density was lower (73.9610.4 vs 97.1618.2 cells.mm
22, P=0.04)
and that of T cells was higher (285.6689.0 vs 155.6631.5
cells.mm
22, P=0.007) in HP compared to NP piglets.
Together with immune cells expansion in the lamina propria,
the neonatal period is an intense period of changes in expression of
molecules involved in the recognition of bacteria by epithelial and
immune cells, such as toll-like receptors (TLR) but also cytokines,
either pro- or anti-inflammatory or regulatory. The HP formula
reduced by 45% TLR2 mRNA level at d 28 of age (P=0.002) but
had no effect on TLR4 and TLR9 mRNA levels (Table 2). It also
modified ileal cytokine profiles with reduction of the pro-
inflammatory IL-1b mRNA level at d 7 (260%, P=0.03) but
no effect on IL-6 and TNF-a mRNA levels (Table 2). Concerning
regulatory cytokines, HP formula modified IL-10 mRNA level that
tended to be higher in HP piglets at d 28 (+65%, P=0.066) while
TGF-b1 mRNA levels tended to be lower in HP compared to NP
piglets at d 28 (234%, P=0.07, Table 2). Finally, IL-4 and IL-13
mRNA levels were too low to be detectable, irrespective of the
group (Table 2).
Table 1. Microbiota in the ileal content or adherent to the
ileal mucosa of NP and HP piglets at d2, d7 and d28.
d2 d7 d28
log CFU.g
21 NP HP NP HP
Content
Total aerobes 7.060.4 6.560.5 8.760.5* 8.960.2 9.260.2
Total anaerobes 6.960.4 6.860.5 8.960.3* 8.960.1 9.060.1
E.coli 5.960.3 6.260.5 8.260.5* 9.060.7 8.760.2
Enterococcus 2.860.8 2.660.6 4.561.5 4.461.4 4.561.6
Lactobacillus 6.960.4 6.360.5 8.760.3* 8.760.1 8.860.1
Adherent
Total aerobes 6.860.3 7.660.6 7.060.3 7.160.4 6.960.7
Total anaerobes 6.460.2 7.460.5 7.260.3 7.460.4 5.361.9
E.coli 5.960.4 7.160.6 7.060.5 6.760.4 6.660.7
Enterococcus 2.060.0 5.061.5 4.060.9 4.761.2 4.061.4
Lactobacillus 6.460.2 7.360.5 5.860.3* 5.661.0 5.561.3
Values are means 6 SE, n=6.
*P,0.05.
doi:10.1371/journal.pone.0019594.t001
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formula since we observed a down-regulation of NF-kB2 (coding
the NF- kB p100 sub-unit), RELA (coding the NF- kB p65 sub-
unit) and NFkBIA (coding IkBa) gene expressions at d 28 (253%,
P=0.003; 275% P=0.03 and 232%, P=0.03 respectively,
Table 2).
These different changes in the immune system were not
associated with any difference in MPO activity in the ileal mucosa
at any age (d 7: NP 1.6460.93 and HP 2.6060.57 U/mg mucosa;
d28: NP 3.3160.91 and HP 4.6860.60 U/mg mucosa, P.0.05).
Plasma IgG and haptoglobin concentrations during the
neonatal period
We sought to see if the modifications of local ileal immune
system development induced by the HP formula could have an
impact at the systemic level. Plasma IgG and haptoglobin
concentrations were lower (tendency for haptoglobin) in HP
compared to NP piglets at d 7 (P=0.03 and 0.06 respectively,
Figure 2).
Ileal sensitivity to inflammation later in life
The modifications in microbiota, epithelial barrier function and
ileal immune system development observed during the neonatal
period in this first experiment encouraged us to investigate if the
HP formula had long-term consequences on intestinal barrier
function and sensitivity to bacterial products in adult life in a
follow-up experiment. Ileal permeability was not different between
the two groups (FD-4: NP 451696 vs HP 390698 ng.cm
22.h
21
and HRP: NP 32611 vs HP 26611 ng.cm
22.h
21,P .0.05). TLR
and cytokine mRNA levels were also not different between the two
groups (Table 3).
Ileal explants challenged with different doses of LPS were used
to evaluate changes in the sensitivity of the mucosa towards
bacterial products. Basal levels of IL-8 and TNFa in explants
culture not stimulated with LPS were not different between the
two groups (data not shown). Addition of LPS (50 to 200 mg/mL)
significantly increased the level of cytokines released in the
medium. However, the ileum of HP pigs exhibited lower levels of
TNFa and IL-8 secretion in response to LPS (Figure 3 A–B). The
Figure 1. Ileal ex vivo permeability of NP and HP piglets. Permeability to FD-4 (A) and HRP (B) in the ileum of 2-d old piglets (grey bars) and of
NP (open bars) and HP (solid bars) piglets at 7 and 28 days of age was determined in Ussing chambers. Values are means 6 SE, n=5–6. *, P,0.05. The
HP formula induced an increase of FD-4 permeability at d 7 and HRP permeability at both d 7 and d 28 in the piglet ileum.
doi:10.1371/journal.pone.0019594.g001
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mRNA levels in the ileal explants from NP pigs compared to the
unchallenged explants. However, such an increase was not
observed in explants from HP pigs (Figure 3 C). TLR4 mRNA
levels after the LPS challenge were under the threshold of
detection, irrespective of the group.
Discussion
The major finding of our study is that feeding piglet neonates a
high protein formula reduces the ileal inflammatory response to
LPS in adulthood. This altered response followed early diet-
induced changes in the developmental profile of intestinal
microbiota, barrier function and immune system. Indeed feeding
neonate piglets a HP formula increased bacterial concentrations in
the ileum while decreasing the number of adherent Lactobacilli to
the mucosa, enhanced ileal permeability to small and large
molecules and seemed to accelerate gut immune system post-natal
development.
High protein diets are known to increase satiety in several
experimental adult animal model and also in humans [15].
Conversely, in the present study, the HP formula increased piglet
growth. Energy intake, calculated on a metabolic weight basis, was
not different between the two groups. Analysis of carcass
composition of these piglets revealed an increase deposition of
protein (+27% of protein) and reduction of adiposity (236% of fat)
in HP piglets [16]. Perirenal and subcutaneous adipose tissue
characteristics and lipid metabolism were also modified by the HP
formula [16]. The increase in piglet growth rate during the
neonatal period in the present study agrees with the conclusion of
a systematic review indicating that high protein intake in neonatal
formula accelerates growth of low birth weight infants [17]. More
recently, a large randomized trial concluded that infants receiving
higher protein content in infant formula during the first year of life
exhibited a greater growth [5]. However, other studies failed to
show such effect [18,19]. The discrepancy between the effect of a
high protein diet in adults and in neonates might account for by
the difference in protein needs at those two periods of life since
protein requirement is the highest in the first month of life [20].
The high protein milk formula significantly increased bacterial
counts in ileal digesta at d 7 in HP piglets, thus accelerating
microbiota colonization during the neonatal period. Other studies
in adult have shown a proliferating effect of dietary proteins or
amino acids on intestinal microbiota [11,12]. The higher load of
dietary protein may lead to incomplete protein digestion in the
small intestine (especially in immature piglets) and a significant
part of alimentary and endogenous protein may reach the distal
ileon and large intestine and be degraded by microbiota proteases
and peptidases [21]. Despite this increase in bacterial concentra-
tions in the luminal contents, the number of bacteria adherent to
the mucosa did not change. On the contrary, the number of
Lactobacillus adherent to the mucosa even decreased at d 7. That
might therefore explain the absence of increase in bacterial
translocation despite the huge increased permeability. Indeed
adherence of bacteria to the mucosal surface rather than
histological changes or alterations of epithelial permeability are
the main factor determining bacterial translocation [22]. More-
over, lower adherence of Lactobacillus may explain the increase in
ileal permeability that we have already observed in low birth
weight piglets fed a high protein formula compared to adequate
protein formula [23] since Lactobacillus are known to enhance gut
barrier function [24,25].
The mucosal immune system is almost completely absent at
birth in the pig, and immune cells appear within the first two
weeks of life to progressively increase with age [26]. The piglet
must therefore rely on maternal immunoglobulins transferred to
the neonate through the colostrum (mainly IgG) during the first 2
days of life [27]. The first antigen-presenting cells appear between
1 day and 2 weeks of life while T cells appearance is slower [27].
Collectively, our data are in favour of an acceleration of the
immune system development with the HP formula. Indeed, the
number of CD3-positive cells is increased in the ileal mucosa of
HP piglets at d 28. Similarly, the age-related decrease of TLR2
and IL-1b mRNA levels and the age-related increase of IL-10
mRNA level seem to occur earlier in HP piglets. The role of
dietary protein in the maturation of the immune system has been
highlighted by a work on protein-deprived mice which had been
fed from weaning till adulthood an amino-acid based diet. These
adult mice had poorly developed GALT resembling suckling mice
[14]. Moreover the commensal microbiota is a major stimulus for
the development of the mucosal immune system as learnt from
germ-free animals [28]. The excess load of antigens (dietary and
bacterial) due to the increased permeability in the ileum seemed to
have modulated the mucosal immune system development in our
piglets. Antigen presenting cells may have captured and processed
antigens to T cells resulting in a higher T cell density in HP
comparatively to NP piglets [29].
We also observed reduced mRNA levels of actors of the NFkB
pathway. NF-kB has a well-described pro-inflammatory activity.
Indeed inflammatory bowel disease and experimental intestinal
inflammation are characterized by NF-kB activation and
increased expression of pro-inflammatory NF-kB target genes;
accordingly, NF-kB inhibition protects against chronic intestinal
inflammation and necrotizing enterocolitis in animal models [30].
However, recent findings suggest that NF-kB has not only pro-
inflammatory but also tissue-protective functions [31]. Down-
Table 2. Toll-like receptors, cytokines and NF-kB subunits
mRNA levels in the ileum of NP and HP piglets.
d2 d7 d28
NP HP NP HP
Toll-like receptors
TLR 2 1.7160.36 0.9860.17 0.8460.12 0.8960.16 0.4860.11*
TLR 4 0.7260.11 0.7060.12 0.7160.09 0.7060.03 0.6660.12
TLR 9 0.4360.08 0.8360.15 1.1960.25 1.2460.26 1.0960.27
Cytokines
IL-1b 1.1760.34 0.7760.28 0.3160.04* 0.3360.05 0.3660.17
IL-6 2.8960.63 1.7560.43 2.2560.51 2.7060.62 2.1260.47
TNFa 0.7760.21 0.7760.13 0.8060.12 2.1060.98 1.4560.52
IL-10 1.6860.35 2.4560.29 2.3160.36 3.1160.49 5.1461.41
#
TGF-b1 0.6060.11 0.7660.09 0.7460.11 0.9960.22 0.6560.16
#
IL-4 n.d. n.d. n.d. n.d. n.d.
IL-13 n.d. n.d. n.d. n.d. n.d.
NF-kB sub-units
NF-kB1 0.2360.03 0.3660.06 0.2260.03 0.3060.04 0.3860.09
NF-kB2 0.3160.06 0.3460.05 0.3060.07 0.3860.06 0.1860.07*
RELA 0.9460.10 1.1060.15 1.3160.28 1.1160.14 0.2860.07*
NF-kBIA 0.5560.12 0.4060.13 0.3560.10 0.4760.08 0.3260.07*
Values are means 6 SE, n=6.
*P,0.05.,
#P#0.07, n.d. not detectable.
doi:10.1371/journal.pone.0019594.t002
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commonly described as a regulatory mechanism to dampen [32]
but also to augment long-term inflammatory responses [33]
rending difficult to interpret the data. The ambiguity between a
pro- or a anti-inflammatory profile is amplified by the fact that at
the systemic level we observed a reduced plasma haptoglobin level
in HP piglets while at the local level, ileal mucosa MPO activity
was not influenced by the diet. Although additional experiments
are required to further clarify the mechanism of intestinal
adaptation to a high protein formula, the down-regulation of
NF-kB sub-units mRNA levels may be driven both by amino
acids, as described for glutamine [34,35] and by specific
commensal species [36].
Our data provide evidences for a long-term impact of neonatal
nutrition in challenging conditions. The HP formula had no
impact on ileal basal physiology later in life with normalized
barrier function and cytokine profile. However, when challenged
with high doses of LPS, the ileal mucosa of HP pigs secreted less
pro-inflammatory cytokines than that of NP pigs. There was also
no increase in NF-kB1 and 2 mRNA levels in response to LPS in
explants from HP pigs as observed in NP ones. Bacterial cell
surface LPS interacts with mucosal TLR4 to stimulate transcrip-
tion and translation of pro-inflammatory cytokines (TNF, IL-6, IL-
8) via the activation of the transcription factor NF-kB [37]. Ileal
explants of HP pigs did respond to LPS stimulation since the level
of pro-inflammatory cytokines released in the medium was
significantly increased with LPS, irrespective of the LPS dose,
compared to the un-stimulated condition. However, while explants
from NP pigs exhibited a nice dose-response to LPS, cytokines
release in HP explants was lower than that of NP pigs for the
highest doses of LPS. TLR4 mRNA levels in the ileal mucosa were
not different between the two groups, Toll-like receptor-4 mRNA
but also the surface protein expression are down-regulated after
LPS challenge in different immune cells [38,39]. Accordingly,
TLR4 mRNA was undetectable in our ileal explant 20 hrs after
Figure 2. IgG and haptoglobin concentrations in the plasma of NP and HP piglets. IgG (A) and haptoglobin (B) concentrations were
determined in the plasma of 2-d old piglets (grey bars) and of NP (open bars) and HP (solid bars) piglets at 7 and 28 days of age. Values are means 6
SE; n=5–6. *, P,0.05 ; #,P #0.06. HP piglets exhibited lower plasma concentrations of IgG and haptoglobin than NP piglets at d 7.
doi:10.1371/journal.pone.0019594.g002
Table 3. Toll-like receptors and cytokines mRNA expression
at d160 of life.
NP HP
Toll-like receptors
TLR2 1.5660.16 1.7960.34
TLR4 0.7760.06 0.8660.14
TLR9 1.1160.17 1.5660.43
Cytokines
IL-1b 0.9860.07 0.8960.11
TNFa 0.9560.18 0.8660.17
IL-10 1.2460.18 0.9060.10
TGF-b1 1.0060.10 1.1060.18
doi:10.1371/journal.pone.0019594.t003
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that TLR4 was not involved in the differential response to LPS
observed between the two dietary groups. Activation of NF-kB
pathway after LPS challenge is an immediate response [32,33]. A
recent paper shows NF-kB pathway activation within 1 h followed
by increase in NF-kB1 mRNA levels 8 h after the challenge in
neuronal cells [40]. Down-regulation of the mRNA levels of NF-
kB sub-units as observed after 20 h of LPS challenge in the HP
group might be a mean to dampen inflammatory response and
explain the lower concentration of cytokines measured in
supernatants of explants form HP pigs.
Adult intestinal mucosa is tolerant to LPS, as demonstrated
by the lower IL-8 secretion in response to LPS of adult intestinal
tissue compared to foetal or neonatal ones [34,41]. Although the
exact mechanisms are not all unravelled, this ensures tolerance
to the resident microbiota in adults. In the present study, ileal
inflammatory response to LPS was similar at the doses of LPS
usually used to demonstrate tolerance to LPS, suggesting that
tolerance to LPS was not altered .T h ed i f f e r e n c eb e t w e e nt h e
two groups was observed at high doses of LPS. Although it is
difficult to extrapolate these ex vivo data to an in vivo situation,
one can speculate that the reduced inflammatory response to
high doses of LPS could have dramatic consequences in case of
need of sustained response to inflammatory challenge in vivo.
There is clearly a need for further investigations to understand
how the impaired development of intestinal immune system
early in life can have consequences later in life. A recent study
has provided evidence of delayed effects of changing early
microbial colonization of the gut on mucosal immune functions
in weaned pigs [42]. In addition a neonatal LPS challenge was
reported to amplify the immune response to experimental
TNBS-induced colitis in rats [43]. Corroborating these findings
we demonstrated that early modulation of ileal microbial
colonization, epithelial barrier and immune development
through nutrition influences ileal immune response to LPS
challenge in adults.
In conclusion, our study demonstrates that the level of protein
in formulas does have immediate consequences on ileal
physiology. Furthermore, such high protein formulas also have
delayed consequences on ileal immune response later in life.
Whether this effect is directly linked to the higher protein content
or also partly to the decrease in fat and carbohydrate content to
keep formula energy constant and the mechanisms remain to be
investigated.
Figure 3. Ileal explant responses to LPS of NP and HP piglets at d 160 of life. TNFa (A) and IL-8 (B) release by ileal explants of 160 day-old
piglets fed either the NP (open squares) or the HP (solid squares) formula from d 2 to d 28 of life was measured in response to different doses of LPS.
NF-kB subunits mRNA levels were measured in explants stimulated with 200 mg/mL of LPS and compared to that of non-stimulated explants (C).
Values are means 6 SE; n=8–10. *, P,0.05., FC fold-change. Ileal explants from HP pigs exhibited less cytokine release in response to high doses of
LPS. Moreover, while NF-kB1 and 2 mRNA levels were increased after challenge with 200 mg/mL LPS in explants from NP pigs, this increase did not
occur in explants from HP ones.
doi:10.1371/journal.pone.0019594.g003
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Ethic statement
The experimental protocol was designed in compliance with
recommendations of the French law (De ´cret: 2001-464 29/05/01)
and EEC (86/609/CEE) for the care and use of laboratory
animals under the certificate of authorization to experiment on
living animals nu7676.
Animals and experimental design
The experiments were performed on 54 crossbred (Pie ´train6(-
Large White6Landrace)) piglets from the experimental herd of
INRA (Saint-Gilles, France) in two separate experiments (short-
term and long-term effects). We used low birth weight piglets (birth
weight 0.9060.02 kg) because of their relative intestinal immatu-
rity [44] to maximize the chance to see an effect of dietary
proteins. In the first experiment (short-term effects), piglets were
separated from sows after colostrum intake at 2 days of life (d 2). A
first group of 6 piglets from 6 litters was sacrificed at d 2 as initial
controls. Then 12 pairs of littermates from 12 different litters were
randomly allocated at d 2 to two artificially reared groups. One
piglet of each pair received a normoprotein formula (NP) and the
other one a high protein formula (HP) (see section below for
feeding procedure details). The use of littermates in each pair
ensured that the genetic but also microbiological backgrounds
within the piglet pair would be close. Between d 2 and d 7, piglets
were placed in incubators (33uC, 60 % humidity), and bottle-fed 9
times a day at 2 h intervals between 7 a.m. and 11 p.m., plus an
extra meal at 3 a.m.. At d 7, 6 pairs of piglets were sacrificed, while
6 other pairs were transferred into individual cages equipped with
an automatic device delivering milk 10 times a day (same schedule)
in a temperature-controlled room at 30uC until d 28 (commonly
the end of the suckling period in pig breeding). Piglets were
sacrificed at d 28.
In the second experiment (long-term effects), 6 pairs of males
and 6 pairs of females were selected at birth and followed exactly
the same feeding protocol from d 2 to d 28 than in the first
experiment. At d 28, piglets were weaned. They were kept in
individuals cages until d 160 and fed the same diet for both groups
(see post-weaning feeding procedure below).
For both experiments, clinical observations were recorded daily.
Piglets were weighed daily from d 2 to d 6 then twice a week until
d 160. Feed intake was recorded daily.
Animal feeding
A NP formula supplying the same amount of nutrient as sow
milk [45] was formulated using whey protein concentrate,
skimmed milk powder and potassium caseinate as main sources
of proteins. The HP formula was designed to provide a 40%
higher amount of protein per day but the same casein/whey
protein ratio and fat to carbohydrate ratio (Table 4). The increase
in protein content of the HP formula was achieved by increasing
the amount of whey protein concentrate and potassium caseinate.
The individual daily milk quantity offered to the piglets was
calculated to provide 1305 kJ.kg
21 of metabolic weight (body
weight
0.75) per day. The amount of protein offered to the HP
piglets was progressively increased (30% higher than NP piglets
from d 2 to d 7 and 40 % higher than NP piglets from d 8
onwards). This was achieved by offering the HP piglets a milk
formula prepared by mixing NP and HP formulas (30/70 v/v)
from d 2 to d 7. Both formula powders were manufactured by the
Laiterie de Montaigu (Montaigu, France). Milk formulas were
prepared daily from powders, maintained at 4uC, and then
warmed up before meal.
In the second experiment, piglets were offered a standard post-
weaning diet from d 28 to d 42 of life and then diets covering their
specific protein and energy requirements but formulated to
provide 30% of energy with lipids as observed in humans
(Table 5). They were fed ad libitum.
Tissue collection
Piglets were euthanized at d 2, d 7, d 28 and d 160 by
electronarcosis and bleeding. At d 2, d 7 and d 28, blood was
collected in heparinized tubes, centrifuged (4000 g, 10 min, 4uC)
and plasma was stored at 220uC. Dissections were performed
under aseptic conditions to sample the spleen and mesenteric
lymph nodes from the lower intestine to evaluate bacterial
translocation. Digestive contents and mucosa from distal ileum
Table 4. Composition of neonatal formula.
NP HP
Ingredients (g/100 g powder)
Lactose 19.7 21.3
palm oil 14.7 13.0
milk fat 14.7 13.0
whey protein concentrate 14.4 20.3
skimmed milk powder 8.9 -
potassium caseinate 8.4 14.8
oleic sunflower oil 5.6 5.0
soybean oil 4.1 3.7
tricalcium phosphate 2.5 2.4
L-proline 1.7 1.5
L-glutamic acid 1 1
L-arginine 0.7 0.6
L-glycine 0.6 0.5
canola oil 0.6 0.6
disodium phosphate 0.5 0.3
vitamin and mineral premix
1 0.5 0.5
L-valine 0.3 0.3
fish oil 0.3 0.3
arachidonic acid 0.3 0.3
L-histidine 0.2 0.2
magnesium chloride 0.2 0.2
choline bitartrate 0.2 0.2
Composition (as fed)
Energy (kJ/kg BW
0.75/d) 1305 1305
Protein (g/kg BW
0.75/d) 14.1 20.0
Fat (g/kg BW
0.75/d) 22.6 20.7
Carbohydrate (g/kg BW
0.75/d) 13.5 12.2
Protein/energy (g/100 kcal)
2 4.4 6.2
1Providing per 100 g: vitamin A (retinol) 442.5 mg as retinyl acetate, vitamin D3
(cholecalciferol) 10.5 mg, vitamin E 0.77 mg as all-racemic a-tocopherol
acetate, vitamin K1 (phylloquinone) 0.28 mg, vitamin C (sodium ascorbate )
75 mg, vitamin B1 0.56 mg as thiamine mononitrate, vitamin PP (nicotinamide)
6 mg, vitamin B2 (riboflavin) 1.10 mg, vitamin B6 (pyridoxine) 1.10 mg, folic
acid 0.21 mg, calcium pantothenate 2.65 mg, vitamin B12 (cyanocobalamin)
2.30 mg, biotin 15.00 mg, iodine 100 mg as potassium iodide, Fe 11.9 mg as
ferrous sulphate, Cu 2.00 mg as copper sulphate, Zn 11.60 mg as zinc
sulphate, Mn 2.99 mg as manganese sulphate, Se 20 mg as sodium selenate.
2The average protein/energy ratio in sow milk is 4.2 g/100 kcal.
doi:10.1371/journal.pone.0019594.t004
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aseptic conditions for bacteria count. Adjacent segments of ileum
were rinsed with cold saline and either placed into Ringer buffer
(composition in mmol.L
21:N a
+ 145, Cl
2 128, PO4
32 0.32, Ca
2+
2, Mg
2+ 1, HCO3
2 25, SO4
22 1, K
+ 6.3) at 4uC for immediate
Ussing chamber analysis, or into RNA later (Applied Biosystems,
Courbaboeuf, France) (cross-section of tissue) at 4uC for 24 h and
then maintained at 220uC for later RT-PCR analysis. Five-
centimeter adjacent segments were also rinsed and fixed in 4 %
formaldehyde buffer for 24 h, dehydrated in ethanol, stored at
4uC before being embedded in paraffin. At d 160, segments of ileal
mucosa were rinsed with cold sterile saline then either placed into
Ringer buffer for Ussing chamber analysis or into RNA later
(cross-section of tissue) at 4uC for 24 h and then maintained at
220uC for later RT-PCR analysis. An adjacent segment was
rinsed twice with PBS supplemented with 1% fetal calf serum
(FCS, Gibco, Invitrogen, Cergy-Pontoise, France) and 0.5 mM
DTT (Sigma-Aldrich, St Quentin Fallavier, France), once with
PBS then placed in a PBS/DMEM (3/1 v/v) solution containing
1% FCS, 5 mg.mL
21 gentamicin (Sigma-Aldrich) and
1.25 mg.mL
21 amphotericin B (Sigma-Aldrich) for immediate
explants culture.
Microbiological methods
Within 1 h after collection, mesenteric lymph node and spleen
samples were weighed (50 to 500 mg) and homogenized
(Kinematica, Polytron, Littau-Lucerne, Switzerland) in 1 mL of
sterile 0.9 % NaCl. Ileal mucosa was weighed (10 to 500 mg) and
gently rinsed with 10 mL sterile 0.9 % NaCl. It was then
homogenized in 1 mL of sterile 0.9 % NaCl. Digestive contents
were weighed (10 to 400 mg) and placed into 1 mL of sterile 0.9 %
NaCl. Samples were then diluted at 1/1000. Ten microliters of
each samples were plated on various selective and nonselective
media to allow numeration of specific bacterial types. Chromo-
genic UTI Medium (Oxoid, Cambridge, UK) was used for the
presumptive identification and differentiation of the main aerobes
(Enterobacteria, Lactobacillus, Enterococcus, Staphylococcus). Columbia
CAN agar +5 % sheep blood (BD Biosciences, Le Pont de Claix,
France) was used for Gram+ bacteria, Schaedler agar +5 % sheep
blood medium (BD Biosciences) for total aerobes and anaerobes,
Schaedler agar with kanamycin/vancomycin (BD Biosciences) for
selective culture of Gram- anaerobes. Man-Rogosa and Sharpe
(MRS) medium (Difco, Detroit, USA) was used for Lactobacillus.
The anaerobic atmosphere was obtained using anaerocult A
(Merk, Darmstadt, Germany). Aerobic and anaerobic cultures
were examined after 24 and 48 h of incubation, respectively.
Bacterial counts of cultured mucosa and contents are expressed as
the log colony-forming units (CFU) per gram of content or tissue.
The count threshold was 10
2 CFU.g
21. Lymphoid tissue translo-
cation was expressed as percentage of positive tissues in each
group.
Ussing chamber
Intestinal tissues were stripped of longitudinal muscle and
opened along the anti-mesenteric border then mounted in Ussing
chamber (World Precision Instrument, Stevenage, UK). The
chamber opening exposed 0.67 cm
2 of tissue surface area to 8 mL
of circulating oxygenated Ringer at 39uC. The serosal buffer
contained 16 mmol.L
21 glucose osmotically balanced by
16 mmol.L
21 mannitol in the mucosal buffer.
The paracellular and transcellular passages were determined
with FITC-4000 (FD-4, Sigma-Aldrich) and horseradish perox-
ydase (HRP Type II, Sigma-Aldrich), respectively. FD-4 and HRP
(375 mg.L
21 each) were added to the mucosal buffer at t0. Five
hundred microliters samples were collected at 30 min intervals for
120 min from the serosal buffer and replaced with Ringer-glucose
buffer to maintain a constant volume within the chambers.
Concentration of FD-4 in the samples was measured by
fluorimetry (fluorimeter LB940 Mithras, Berthold Technologies,
Thoiry, France) while concentration of HRP was determined using
spectrophotometry (Multiskan spectrum, Thermo Labsystem,
Midland, Canada) after enzymatic reaction using o-dianisidine
as substrate (Sigma-Aldrich). Mucosal-to-serosal fluxes were then
calculated and expressed as ng.cm
22.h
21.
Myeloperoxidase (MPO) assay
Myeloperoxidase (MPO) activity was determined in ileal
mucosa using an O-dianisidine-hydrogen hydroperoxide method
[46] after MPO had been extracted from tissues according to
Barreau et al. [47].
Explant culture
Explant culture protocol was adapted from Coeffier et al. and
Nanthakumar et al. [41,48]. Briefly, ileal mucosa was cut in small
pieces of 10–15 mg which were let in a DMEM solution
containing 1% FCS, 5 mg.mL
21 gentamicin, 1.25 mg.mL
21
amphotericin, 100 U.mL
21 penicillin (Gibco), 100 mg.mL
21
streptomycin (Gibco), 2 mM L-glutamine (Gibco) and 1 mM
sodium pyruvate (Gibco) for 2 h under a 95% CO2-5% O2
atmosphere at 37uC. Explants were then transferred into the same
DMEM solution as previously described but without FCS (2 pieces
i.e. 20–35 mg of mucosa per mL) and either 0, 50, 100 or 200 mg/
mL LPS (Sigma-Aldrich) and incubated for 20 h under a 95%
CO2-5% O2 atmosphere at 37uC. At that time, supernatants were
immediately frozen and stored at 220uC for later cytokines
analysis and tissues were frozen at 280uC in Trizol reagent
(Invitrogen) for later mRNA extraction. IL-8 and TNFa
concentrations in the supernatants were determined by ELISA
(R&D Systems Europe, Lille, France).
Quantitative RT-PCR analysis
Total RNA was extracted from tissues with Trizol reagent and
chloroform, precipitated by isopropanol. Ethanol was then used to
wash the precipitate, which was hydrated with 100 mL of water.
Extracted RNA were quantified by spectrophotometry (Nanodrop,
Wilmington, USA) and treated by the DNA-free kit (Ambion,
Austin, USA). Their quality was assessed by fluorimetry by the
RNA 6000 nano LabChipH kit in 2100 Bioanalyser (Agilent
Biotechnologies, Santa Clara, USA). Reverse transcription was
performed with 2 mg of total RNA using the High capacity cDNA
archive kit (Applied Biosystems). Obtained cDNA were amplified
using specific primers for TLR2, TLR4, TLR9, IL-1b, IL-6, TNF-
Table 5. Composition of the weaning diet and the diets
offered until d160 of life.
weaning diet
(d29–d42) d43–d70 diet d71–d160 diet
g/100 g dry matter
Protein 19.5 21.6 19.0
Fat 6.6 11.8 11.8
Fiber 3.0 3.2 3.3
energy (MJ/kg) 10.61 11.15 11.16
doi:10.1371/journal.pone.0019594.t005
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13 genes (Table S1). The real time quantitative PCR were
performed with the obtained cDNA, both forward and reverse
primers (500 nmol.L
21), Uracyl-DNA-glycosylase (Invitrogen) and
SYBRH Green I PCR core reagents (Applied Biosystems) in an
ABI PRISM 7000 Sequence Detection System instrument
(Applied Biosystems). Forty cycles of amplification were performed
(denaturation at 95uC for 15 s, annealing and extention at 60uC
for 1 min). Amplification product specificity was checked by
dissociation curve analyses. To determine the efficiency of each
primer, a standard curve was established from serial dilutions of a
RT product sample pool. Then, for each sample, the relative
amount of the target RNA was determined by comparison with
the corresponding standard curve. Finally, the transcript level was
normalized to the transcript level of GAPDH (housekeeping gene,
see Table S1 for primer sequence) in the same sample.
Fluorescence immunohistochemistry
The postnatal development of gut immune cells was focused on
CD172
+ myeloid cells, i.e. granulocytes, monocytes, macrophages
and dendritic cells and CD3
+ T cells. Five-micrometer paraffin
sections were rehydrated in toluene (3 washes of 10 min) and in
ethanol (3 washes of 5 min). To unmask leukocyte antigens, tissue
sections were incubated twice in 10 mM Tris-EDTA buffer, pH
9.0, for 3–5 min at 650 W using a microwave oven (VIP20,
Whirlpool Philips, Sweden). Sections were left 20 min at room
temperature after each microwave treatment. After one wash for
5 min in PBS, sections were simultaneously incubated with FITC-
conjugated anti-porcine CD3 (clone PPT3, IgG1 isotype, Beck-
man Coulter, Krefeld, Germany) at 20 mg.L
21 and red phyco-
erythrin anti-porcine CD172 (clone 74-22-15, IgG1 isotype,
Beckman Coulter) at 10 mg.L
21. In parallel, conjugated mouse
F(ab9)2 IgG1 isotype controls (Southern Biotechnology Associates,
Birmingham, USA) were used as negative controls. One ileal
section of each animal was observed using a Nikon ECLIPSE
E400 epifluorescence microscope (Nikon, Tokyo, Japan). Ten
representative areas of 0.14 mm
2 each were recorded with CCD
camera (Nikon DXM 1200, 5.3 version,Nikon) and CD3
+ cells
and CD172
+ cells were counted by NIS software (Nikon
Instruments Inc., Melville, USA). Results are expressed as positive
cell number.mm
22.
Plasma IgG and haptoglobin concentrations
IgG levels were determined in the plasma by quantitative
ELISA sandwich using a pig dedicated ELISA kit (Bethyl Pig IgG
ELISA quantitation kit, Interchim, Montluc ¸on, France). Hapto-
globin concentrations were determined in the plasma by a pig
dedicated colorimetric kit (Tridelta Ltd, Maynooth, Ireland).
Statistical analyses
Statistical analyses were performed using the General Linear
Model procedure of Statistical Analysis Systems software (SAS
Institute, Cary, NC, USA), testing the piglet pair, age, diet and
age6diet interaction, with t-test as a subsequent multiple
comparisons when appropriate. Translocation data were analysed
using the non parametric chi2-test. All results are presented as
means 6 SE. Differences between groups were declared significant
at P,0.05.
Supporting Information
Table S1 Primers used in real-time PCR. S=sense
primer, AS=anti-sense primer. The primers were designed using
Primer Express Software (Applied Biosystems) based on sus scrofa
published nucleotide sequences (Iccare, http://bioinfo.genopole-
toulouse.prd.fr/Iccare/)
(DOC)
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